18F-FDG

Construction and Clinical Translation of ACE Targeted Nuclear Medicine Imaging Probe

Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes

PD-L1 Specific [68Ga]Ga-THP-PDL1-3 Probe for PET Imaging in Solid Tumors

Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity

68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma

Single-tracer Multiparametric PET Imaging

18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer

18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Disease

Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Imaging

Assessing Granulomatosis With Polyangiitis Activity: 18F-FDG PET/CT vs BVAS v3

Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging

Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution

Multi-organ Imaging of Microvascular and Metabolic Function

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors

Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET

Application and Comparison of [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI in Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients